文献速递肿瘤 PET/CT

宫颈癌[18F]-FDG PET/CT代谢肿瘤体积勾画的最优方法及观察者间一致性

Optimal method for metabolic tumour volume assessment of cervical cancers with inter-observer agreement on [18F]-fluoro-deoxy-glucose positron emission tomography with computed tomography.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2020-12-11

本研究以MRI肿瘤体积为参考标准,纳入81例宫颈癌患者的治疗前[18F]-FDG PET/CT,比较三种MTV勾画方法。方法1在25%和30% SUVmax阈值下MTV最接近MRI体积,但MTV30观察者间一致性优秀且需手动调整的病灶比例更低(45% vs 70%)。结论认为MTV30是与MRI体积相关性最优的勾画方法。

要点

  • MTV30与MRI肿瘤体积最接近,且观察者间一致性优秀(ICC 0.898–0.976)。
  • MTV25需手动调整的病灶比例高于MTV30(70% vs 45%)。
  • 方法2各阈值ICC均优秀且无需手动调整,但部分阈值与MRI偏差较大。

核心结论

  • 综合与MRI体积的相关性、观察者间一致性及手动调整需求,MTV30为最优宫颈癌原发肿瘤勾画方法。

研究设计与样本

  • 回顾性纳入81例连续宫颈癌患者,均有治疗前分期MRI和[18F]-FDG PET/CT图像。
  • 以MRI勾画的肿瘤体积为参考标准,比较三种PET勾画方法及观察者间一致性。

主要发现

  • 方法1中MTV25和MTV30最接近MRI体积:读者1和读者2的MTV25相对MRI体积平均变化分别为2.9%和13.4%,MTV30分别为-13.1%和-2.0%。
  • 方法1中MTV30至MTV60观察者间一致性优秀(ICC 0.898–0.976,95%CI窄);MTV20和MTV25一致性中等(ICC分别为0.534和0.617,95%CI宽)。
  • 方法1中需手动调整的病灶比例在MTV25为70%、MTV30为45%;膀胱遮蔽总体用于86%的病例。
  • 方法2在MTV25和MTV30与MRI相关性优秀(读者1和读者2的MTV25平均变化-3.9%和-8.6%,MTV30为-16.9%和19%),所有阈值ICC优秀且无需手动调整。
  • 方法3 ICC为0.96(95%CI 0.94–0.97),但相对MRI体积平均差异为读者1 -19.1%、读者2 -18.2%,两名读者均有21%病例需手动调整。

关键数值与推荐

  • 方法1:在SUVmax 20%–60%阈值范围测量MTV(MTV20–MTV60),必要时膀胱遮蔽并手动调整。
  • 方法2:先围绕肿瘤创建等轮廓,再应用不同SUVmax阈值。
  • 方法3:采用自动梯度法勾画。

临床怎么用

  • 宫颈癌[18F]-FDG PET/CT代谢肿瘤体积勾画可优先选择SUVmax 30%阈值,以兼顾与MRI体积的一致性和观察者间可重复性。
  • 使用较低阈值(如20%–25%)时需注意观察者间一致性下降及手动调整需求增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Cervical cancer metabolic tumour volume (MTV) derived from [18F]-FDG PET/CT has a role in prognostication and therapy planning. There is no standard method of outlining MTV on [18F]-FDG PET/CT. The aim of this study was to assess the optimal method to outline primary cervical tumours on [18F]-FDG PET/CT using MRI-derived tumour volumes as the reference standard. METHODS: 81 consecutive cervical cancer patients with pre-treatment staging MRI and [18F]-FDG PET/CT imaging were included. MRI volumes were compared with different PET segmentation methods. Method 1 measured MTVs at different SUVmax thresholds ranging from 20 to 60% (MTV20-MTV60) with bladder masking and manual adjustment when required. Method 2 created an isocontour around the tumour prior to different SUVmax thresholds being applied. Method 3 used an automated gradient method. Inter-observer agreement of MTV, following manual adjustment when required, was recorded. RESULTS: For method 1, the MTV25 and MTV30 were closest to the MRI volumes for both readers (mean percentage change from MRI volume of 2.9% and 13.4% for MTV25 and - 13.1% and - 2.0% for MTV30 for readers 1 and 2). 70% of lesions required manual adjustment at MTV25 compared with 45% at MTV30. There was excellent inter-observer agreement between MTV30 to MTV60 (ICC ranged from 0.898-0.976 with narrow 95% confidence intervals (CIs)) and moderate agreement at lower thresholds (ICC estimates of 0.534 and 0.617, respectively for the MTV20 and MTV25 with wide 95% CIs). Bladder masking was performed in 86% of cases overall. For method 2, excellent correlation was demonstrated at MTV25 and MTV30 (mean % change from MRI volume of -3.9% and - 8.6% for MTV25 and - 16.9% and 19% for MTV30 for readers 1 and 2, respectively). This method also demonstrated excellent ICC across all thresholds with no manual adjustment. Method 3 demonstrated excellent ICC of 0.96 (95% CI 0.94-0.97) but had a mean percentage difference from the MRI volume of - 19.1 and - 18.2% for readers 1 and 2, respectively. 21% required manual adjustment for both readers. CONCLUSION: MTV30 provides the optimal correlation with MRI volume taking into consideration the excellent inter-reader agreement and less requirement for manual adjustment.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Arshad MA, Gitau S, Tam H, et al. Optimal method for metabolic tumour volume assessment of cervical cancers with inter-observer agreement on [18F]-fluoro-deoxy-glucose positron emission tomography with computed tomography. Eur J Nucl Med Mol Imaging. 2020. PMID: 33313962. doi:10.1007/s00259-020-05136-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。